Bringhen, Sara; Milan, Alberto; Ferri, Claudio; Wäsch, Ralph; Gay, Francesca; Larocca, Alessandra; Salvini, Marco; Terpos, Evangelos; Goldschmidt, Hartmut; Cavo, Michele; Petrucci, Maria Teresa; Ludwig, Heinz; Auner, Holger W; Caers, Jo; Gramatzki, Martin; Boccadoro, Mario; Einsele, Hermann; Sonneveld, Pieter; Engelhardt, Monika, Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA), «HAEMATOLOGICA», 2018, 103, pp. 1422 - 1432 [Scientific article]Open Access
Fontana, Maria Chiara*; Marconi, Giovanni; Feenstra, Jelena D. Milosevic; Fonzi, Eugenio; Papayannidis, Cristina; Ghelli Luserna Di Rorá, Andrea; Padella, Antonella; Solli, Vincenza; Franchini, Eugenia; Ottaviani, Emanuela; Ferrari, Anna; Baldazzi, Carmen; Testoni, Nicoletta; Iacobucci, Ilaria; Soverini, Simona; Haferlach, Torsten; Guadagnuolo, Viviana; Semerad, Lukas; Doubek, Michael; Steurer, Michael; Racil, Zdenek; Paolini, Stefania; Manfrini, Marco; Cavo, Michele; Simonetti, Giorgia; Kralovics, Robert; Martinelli, Giovanni, Chromothripsis in acute myeloid leukemia: Biological features and impact on survival, «LEUKEMIA», 2018, 32, pp. 1609 - 1620 [Scientific article]Open Access
Soverini, Simona; Mancini, Manuela; Bavaro, Luana; Cavo, Michele; Martinelli, Giovanni, Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy, «MOLECULAR CANCER», 2018, 17, pp. 1 - 15 [Scientific article]Open Access
D. Sollazzo, D. Forte, G. Simonetti, S. Bruno, M. Barone, G. Auteri, E. Ottaviani, M. Romano, G. Martinelli, N. Vianelli, M. Cavo, F. Palandri, L. Catani, CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS, in: Haematologica XV Congress of the Italian Society of Experimental Hematology Rimini, Italy, October 18-20, 2018 ABSTRACT BOOK, 2018(atti di: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy, October 18-20, 2018) [Poster]
Stefoni, Vittorio; Broccoli, Alessandro; Argnani, Lisa; Sabattini, Elena; Cavo, Michele; Zinzani, Pier Luigi, Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2018, 18, pp. 297 - 299 [Scientific article]
Usmani, Saad Z; Hoering, Antje; Cavo, Michele; Miguel, Jesus San; Goldschimdt, Hartmut; Hajek, Roman; Turesson, Ingemar; Lahuerta, Juan Jose; Attal, Michel; Barlogie, Bart; Lee, Jae Hoon; Kumar, Shaji; Lenhoff, Stig; Morgan, Gareth; Rajkumar, S Vincent; Durie, Brian G M; Moreau, Philippe, Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project, «BLOOD CANCER JOURNAL», 2018, 8, pp. 123 - 123 [Scientific article]Open Access
Latagliata, Roberto; Polverelli, Nicola; Tieghi, Alessia; Palumbo, Giuseppe Alberto; Breccia, Massimo; Sabattini, Elena; Villari, Loredana; Riminucci, Mara; Valli, Riccardo; Catani, Lucia; Alimena, Giuliana; Ottaviani, Emanuela; Fama, Angelo; Martinelli, Giovanni; Perricone, Margherita; Spinsanti, Marco; Cavo, Michele; Vianelli, Nicola; Palandri, Francesca, Comparison of JAK2V617F-positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology, «HEMATOLOGICAL ONCOLOGY», 2018, 36, pp. 269 - 275 [Scientific article]
Musto, P; Anderson, K. C; Attal, M; Richardson, P. G; Badros, A; Hou, J; Comenzo, R; Du, J; Durie, B. G. M; San Miguel, J; Einsele, H; Chen, W. M; Garderet, L; Pietrantuono, G; Hillengass, J; Kyle, R. A; Moreau, P; Lahuerta, J. J; Landgren, O; Ludwig, H; Larocca, A; Mahindra, A; Cavo, M; Mazumder, A; Mccarthy, P. L; Nouel, A; Rajkumar, S. V; Reiman, A; E, Riva; Sezer, O; Terpos, E; Turesson, I; Usmani, S; Weiss, B. M; Palumbo, A., Corrigendum: Second primary malignancies in multiple myeloma: an overview and IMWG consensus, «ANNALS OF ONCOLOGY», 2018, 29, pp. 1074 - 1074 [Scientific article]
Spencer, Andrew; Lentzsch, Suzanne; Weisel, Katja; Avet-Loiseau, Hervé; Mark, Tomer M; Spicka, Ivan; Masszi, Tamas; Lauri, Birgitta; Levin, Mark-David; Bosi, Alberto; Hungria, Vania; Cavo, Michele; Lee, Je-Jung; Nooka, Ajay K; Quach, Hang; Lee, Cindy; Barreto, Wolney; Corradini, Paolo; Min, Chang-Ki; Scott, Emma C; Chanan-Khan, Asher A; Horvath, Noemi; Capra, Marcelo; Beksac, Meral; Ovilla, Roberto; Jo, Jae-Cheol; Shin, Ho-Jin; Sonneveld, Pieter; Soong, David; Casneuf, Tineke; Chiu, Christopher; Amin, Himal; Qi, Ming; Thiyagarajah, Piruntha; Sasser, A Kate; Schecter, Jordan M; Mateos, Maria-Victoria, Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR, «HAEMATOLOGICA», 2018, 103, pp. 2079 - 2087 [Scientific article]Open Access
Mateos, María-Victoria; Dimopoulos, Meletios A; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Kaplan, Polina; Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna M; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung-Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Chiu, Christopher; Wang, Jianping; Carson, Robin; Crist, Wendy; Deraedt, William; Nguyen, Huong; Ming, Qi; San-Miguel, Jesus for the ALCYONE Trial Investigators, Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2018, 378, pp. 518 - 528 [Scientific article]
Palandri F, Palumbo GA, Iurlo A, Polverelli N, Benevolo G, Breccia M, Abruzzese E, Tiribelli M, Bonifacio M, Tieghi A, Isidori A, Martino B, Sgherza N, D'Adda M, Bergamaschi M, Crugnola M, Cavazzini F, Bosi C, Binotto G, Auteri G, Latagliata R, Ibatici A, Scaffidi L, Penna D, Cattaneo D, Soci F, Trawinska M, Russo D, Cuneo A, Semenzato G, Di Raimondo F, Aversa F, Lemoli RM, Heidel F, Reggiani MLB, Bartoletti D, Cavo M, Catani L, Vianelli N., Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎, «SEMINARS IN HEMATOLOGY», 2018, 55, pp. 248 - 255 [Scientific article]Open Access
Palandri, Francesca; Palumbo, Giuseppe A; Bonifacio, Massimiliano; Breccia, Massimo; Latagliata, Roberto; Martino, Bruno; Polverelli, Nicola; Abruzzese, Elisabetta; Tiribelli, Mario; Nicolosi, Maura; Bergamaschi, Micaela; Tieghi, Alessia; Iurlo, Alessandra; Sgherza, Nicola; Cavazzini, Francesco; Isidori, Alessandro; Binotto, Gianni; Ibatici, Adalberto; Crugnola, Monica; Heidel, Florian; Bosi, Costanza; Bartoletti, Daniela; Auteri, Giuseppe; Catani, Lucia; Cuneo, Antonio; Aversa, Franco; Semenzato, Gianpietro; Cavo, Michele; Vianelli, Nicola; Benevolo, Giulia, Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients, «LEUKEMIA RESEARCH», 2018, 74, pp. 86 - 88 [Scientific article]
Palandri, Francesca; Tiribelli, Mario; Benevolo, Giulia; Tieghi, Alessia; Cavazzini, Francesco; Breccia, Massimo; Bergamaschi, Micaela; Sgherza, Nicola; Polverelli, Nicola; Crugnola, Monica; Isidori, Alessandro; Binotto, Gianni; Heidel, Florian H.; Buccisano, Francesco; Martino, Bruno; Latagliata, Roberto; Spinsanti, Marco; Kallenberg, Lydia; Palumbo, Giuseppe Alberto; Abruzzese, Elisabetta; Scaffidi, Luigi; Cuneo, Antonio; Cavo, Michele; Vianelli, Nicola; Bonifacio, Massimiliano, Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study, «HEMATOLOGICAL ONCOLOGY», 2018, 36, pp. 285 - 290 [Scientific article]
Polverelli, Nicola*; Palumbo, Giuseppe A.; Binotto, Gianni; Abruzzese, Elisabetta; Benevolo, Giulia; Bergamaschi, Micaela; Tieghi, Alessia; Bonifacio, Massimiliano; Breccia, Massimo; Catani, Lucia; Tiribelli, Mario; D'Adda, Mariella; Sgherza, Nicola; Isidori, Alessandro; Cavazzini, Francesco; Martino, Bruno; Latagliata, Roberto; Crugnola, Monica; Heidel, Florian; Bosi, Costanza; Ibatici, Adalberto; Soci, Francesco; Penna, Domenico; Scaffidi, Luigi; Aversa, Franco; Lemoli, Roberto M.; Vitolo, Umberto; Cuneo, Antonio; Russo, Domenico; Cavo, Michele; Vianelli, Nicola; Palandri, Francesca, Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients, «HEMATOLOGICAL ONCOLOGY», 2018, 36, pp. 561 - 569 [Scientific article]
Caers, Jo; Garderet, Laurent; Kortüm, K Martin; O'Dwyer, Michael E; van de Donk, Niels W C J; Binder, Mascha; Dold, Sandra Maria; Gay, Francesca; Corre, Jill; Beguin, Yves; Ludwig, Heinz; Larocca, Alessandra; Driessen, Christoph; Dimopoulos, Meletios A; Boccadoro, Mario; Gramatzki, Martin; Zweegman, Sonja; Einsele, Hermann; Cavo, Michele; Goldschmidt, Hartmut; Sonneveld, Pieter; Delforge, Michel; Auner, Holger W; Terpos, Evangelos; Engelhardt, Monika, European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when, «HAEMATOLOGICA», 2018, 103, pp. 1772 - 1784 [Scientific article]Open Access
